The influence of hepatic impairment on the pharmacokinetics of the dipeptidyl peptidase IV (DPP-4) inhibitor vildagliptin von HE, Y.-L, SABO, R, CAMPESTRINI, J, WANG, Y, LIGUEROS-SAYLAN, M, LASSETER, K. C, DILZER, S. C, HOWARD, D, DOLE, W. P

Volltext

FTY720 Pharmacokinetics in Mild to Moderate Hepatic Impairment von Kovarik, J. M., Schmouder, R. L., Serra, D., Wang, Y., Wiegand, H., Dilzer, S. C., Lasseter, K. C.

Volltext

Disposition of Caspofungin: Role of Distribution in Determining Pharmacokinetics in Plasma von STONE, Julie A, XIN XU, SINGH, Romi, DELUNA, Florencia, DILZER, Stacy C, LASSETER, Kenneth C, WINCHELL, Gregory A, DEUTSCH, Paul J, PEARSON, Paul G, MIGOYA, Elizabeth M, MISTRY, Goutam C, LIWEN XI, MILLER, Alisha, SANDHU, Punam

Volltext

Pharmacokinetics and Pharmacodynamics of Zolmitriptan in Patients with Mild to Moderate Hypertension: A Double-Blind, Placebo-Controlled Study von Smith, Deborah A., Cleary, Elena W., Watkins, Stephanie, Huffman, Cameron S., Dilzer, Stacy C., Lasseter, Kenneth C.

Volltext

Pharmacokinetics of Etoricoxib in Patients with Hepatic Impairment von Agrawal, Nancy G. B., Rose, Mark J., Matthews, Catherine Z., Woolf, Eric J., Porras, Arturo G., Geer, Leslie A., Larson, Patrick J., Cote, Josee, Dilzer, Stacy C., Lasseter, Kenneth C., Alam, Imtiaz, Petty, Kevin J., Gottesdiener, Keith M.

Volltext

Potential for Interactions between Caspofungin and Nelfinavir or Rifampin von STONE, Julie A, MIGOYA, Elizabeth M, LASSETER, Kenneth C, KRAFT, Walter K, GREENBERG, Howard, WALDMAN, Scott A, HICKEY, Lisa, WINCHELL, Gregory A, DEUTSCH, Paul J, GHOSH, Kalyan, FREEMAN, Amanda, SHENG BI, DESAI, Rajesh, DILZER, Stacy C

Volltext

Pharmacokinetics of Sirolimus (Rapamycin) in Subjects With Mild to Moderate Hepatic Impairment von Zimmerman, James J., Lasseter, Kenneth C., Lim, Heng-Keang, Harper, Dawn, Dilzer, Stacey C., Parker, Vernon, Matschke, Kyle

Volltext

Influence of hepatic impairment on everolimus pharmacokinetics: Implications for dose adjustment von Kovarik, J

Volltext

Pharmacokinetics of Long-Acting Naltrexone in Subjects With Mild to Moderate Hepatic Impairment von Turncliff, Ryan Z., Dunbar, Joi L., Dong, Qunming, Silverman, Bernard L., Ehrich, Elliot W., Dilzer, Stacy C., Lasseter, Kenneth C.

Volltext

Pharmacokinetics and safety of Ebastine in patients with impaired hepatic function compared with Healthy volunteers: A phase I open-label study von LASSETER, Kenneth C, DILZER, Stacy C, VARGAS, Ramon, WALDMAN, Scott, NOVECK, Robert J

Volltext

Influence of hepatic impairment on everolimus pharmacokinetics: Implications for dose adjustment von Kovarik, John M., Sabia, Helene D., Figueiredo, Joaquim, Zimmermann, Heidrun, Reynolds, Christine, Dilzer, Stacy C., Lasseter, Kenneth, Rordorf, Christiane

Volltext

Evaluation of the Single-dose Pharmacokinetics of Bilastine in Subjects with Various Degrees of Renal Insufficiency von Lasseter, Kenneth C., Sologuren, Ander, La Noce, Anna, Dilzer, Stacy C.

Volltext

Safety and pharmacokinetics of multiple doses of aclidinium bromide administered twice daily in healthy volunteers von Lasseter, K, Dilzer, S, Jansat, J.M, Garcia Gil, E, Caracta, C.F, Ortiz, S

Volltext

Single- and Multiple-Dose Administration of Caspofungin in Patients With Hepatic Insufficiency: Implications for Safety and Dosing Recommendations von Mistry, Goutam C., Migoya, Elizabeth, Deutsch, Paul J., Winchell, Gregory, Hesney, Michael, Li, Susan, Bi, Sheng, Dilzer, Stacy, Lasseter, Kenneth C., Stone, Julie A.

Volltext

Interactions between Simvastatin and Troglitazone or Pioglitazone in Healthy Subjects von Prueksaritanont, Thomayant, Vega, José M., Zhao, Jamie, Gagliano, Kathleen, Kuznetsova, Olga, Musser, Bret, Amin, Raju D., Liu, Lida, Roadcap, Brad A., Dilzer, Stacy, Lasseter, K. C., Rogers, J. Douglas

Volltext

Intravenous conivaptan: effects on the QTc interval and other electrocardiographic parameters in healthy volunteers von Lasseter, Kenneth C, Dilzer, Stacy C, Smith, Neila

Volltext

IL-2 and antigen dose differentially regulate perforin- and FasL-mediated cytolytic activity in antigen specific CD4 super(+) T cells von Brown, D M, Kamperschroer, C, Dilzer, A M, Roberts, D M, Swain, S L

Volltext

PII-49Lack of clinically significant effect of moderate hepatic insufficiency on the pharmacokinetics of MK-0431 (sitagliptin), a dipeptidyl-peptidase-IV (DPP-IV) inhibitor von STEVENS, C, BERGMAN, A, LIU, Q, LUO, W, WANG, A, ZENG, W, LASSETER, K, DILZER, S, WAGNER, J, HERMAN, G

Volltext

Dose-proportionality of a final market image sitagliptin formulation, an oral dipeptidyl peptidase-4 inhibitor, in healthy volunteers von Bergman, Arthur, Mistry, Goutam C., Luo, Wen-Lin, Liu, Q., Stone, Julie, Wang, Amy, Zeng, Wei, Chen, Li, Dilzer, Stacy, Lasseter, Kenneth, Herman, Gary A., Wagner, John A., Krishna, Rajesh

Volltext

PII-49 von Stevens, C., Bergman, A. J., Liu, Q., Luo, W., Wang, A. Q., Zeng, W., Lasseter, K. C., Dilzer, S., Wagner, J. A., Herman, G. A., Migoya, E.

Volltext